Many of the frozen programs are aimed at alleviating disease and malnutrition, but even security programs with U.S. funding ...

DURECT Corporation today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM Evidence. The full article, entitled, "Larsucosterol for the Treatment of ...

( MENAFN - GlobeNewsWire - Nasdaq) The U.S. antimicrobial susceptibility testing market is projected to grow at a 4.9% CAGR (2025 to 2035), driven by rising antibiotic resistance, advanced healthcare, ...

CJD is rare but fatal. The UK NHS lists possible symptoms including loss of intellect and memory, changes in personality, ...

Senator Tim Kaine, Democrat of Virginia, quickly condemned the Trump administration’s offer to roughly 2 million federal ...

Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...